Clinical and biological differences between CD44v5 positive infiltrating ductal carcinomas of the breast, classified on the basis of hyaluronic acid concentration in the cell membrane;Diferencias clinicobiológicas de los carcinomas ductales infiltrantes de mama CD44v5 positivos clasificados en función de la concentración de ácido hialurónico de la membrana celular

Cirugia Espanola

Volumn 69, Issue 5, 2001, Pages 451-454

  Ruibal, A ^a,b   Arias, J ^c   Suarez A ^d   del Rio M C ^e   Lapena G ^a,b   Schneider, J ^b,f   Tejerina, A ^b,f  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b Fundacion Tejerina   (Spain)

^c Hospital Monte del Naranco   (Spain)

^d HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^e Hospital de Barbanza   (Spain)

^f Centro de Patologia de la Mama   (Spain)

Author keywords

Breast tumors; CD44v5; Hyaluronic acid

Indexed keywords

EID: 84897768613     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(01)71780-0     Document Type: Article

References (27)

1. Herrera-Gayol A, Jothy S. CD44 modulates Hs5787T human breast cancer cell adhesion, migration and invasiveness. Exp Mol Pathol 1999; 66: 99-108.
2. Ladeda V, Aguirre Ghiso JA, Bal de Kier Joffe E. Function and expression of CD44 during spreading, migration and invasion of murine carcinoma cells. Exp Cell Res 1998; 242: 515-527.
3. Kainz C, Tempfer C. CD44 as a differentiation marker and metastasis promoter in gynecological malignancies. The Cancer Journal 1997; 10: 306-309.
4. Underhill C. CD44: The hyaluronan receptor. J Cell Science 1992; 103: 293-298.
5. Kimata K, Honma Y, Okayama M, Oguri K, Hozumi M, Suzuki S. Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential. Cancer Res 1983; 43: 1347-1354.
6. Bertrand P, Girard N, Delpech B, Duval C, D'Anjou J, Dauce JP. Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of breast carcinomas: comparison between invasive and non invasive areas. Int J Cancer 1992; 52: 1-6.
7. Lokeshwar VB, Young MJ, Goudarzi G, Iida N, Yudin AI, Cherr GN et al. Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1. Cancer Res 1999; 59: 4464-4470.
8. Madan AK, Yu K, Dhurandhar N, Cullinane C, Pang V, Beech DJ. Association of hyaluronidase and breast adenocarcinoma invasiveness. Oncol Rep 1999; 6: 607-609.
9. Itano N, Sawai T, Miyaishi O, Kimata K. Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells. Cancer Res 1999; 59: 2499-2504.
10. Victor R, Chauzy C, Girard N, Gionni J, D'Anjou J, Stora De Novion H et al. Human breast-cancer metastasis formation in a nudemouse model: studies of hyaluronidase, hyaluronan and hyaluronanbinding sites in metastatic cells. Int J Cancer 1999; 82: 77-83.
11. Till KJ, Zuzel M, Cawley JC. The role of hyaluronan and interleukin 8 in the migration of chronic lymphocytic leukemia cells within lymphoreticular tissues. Cancer Res 1999; 59: 4419-4426.
12. Ylagan LR, Quinn B. CD44 expression in astrocytic tumors. Mod Pathol 1997; 10: 1239-1246.
13. Gunia S, Hussein S, Radu DL, Putz KM, Breyer R, Hecker H et al. CD44s-targeted treatment with monoclonal antibody blocks intracerebral invasion and growth of 9L gliosarcoma. Clin Exp Metastasis 1999; 17: 221-230.
14. Sinn HP, Heider KH, Skroch-Angel P, Von Minckwitz G, Kaufamann M, Herrlich P et al. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44. Breast Cancer Res Treat 1995; 36: 307-313.
15. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 1995; 345: 615-619.
16. Ristamaki R, Joensuu H, Sonderstrom KO, Jalkanen S. CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis. J Pathol 1995; 176: 259-267.
17. Hefler L, Tempfer C, Haeusler G, Kucera E, Mayerhofer K, Seillinger R et al. Cytosol concentrations of CD44 isoforms in breast cancer tissue. Int J Cancer 1998; 79: 541-545.
18. Tempfer C, Losch A, Heinzl H, Hausler G, Hanzal E, Kolb H et al. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Eur J Cancer 1996; 32: 2023-2025.
19. Núñez MI, Arias JI, Del Río MC, Martínez MI, Alba A, Allende MT et al. Cell surface CD44v5 levels correlate with progesterone receptors and a tumor size > 2 cm in infiltrating ductal carcinoma of the breast. Int J Biol Markers 1996; 11: 220-222.
20. Knupfer MM, Poppenborg H, Hostfilder M, Kuhnel K, Wolff JE, Domula M. CD44 expression and hyaluronic binding of malignant glioma cells. Clin Exp Metastasis 1999; 17: 71-76.
21. Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 1999; 13: 35-48.
22. Yu Q, Toole BP, Stamenkovic I. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med 1997; 186: 1985-1996.
23. Hitzemen J,Woost PG, Hosick HL. Correlation of hyaluronic acid accumulation and the growth of preneoplastic mammary cells in collagen: a longitudinal study. In Vitro Cell Dev Biol 1992; 28: 284-292.
24. Culty M, Shizari M, Thompson EW, Underhill CB. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J Cell Physiol 1994; 160: 275-286.
25. Foekens JA, Look MP, Bolt-De Vries J, Meijer-Van Gelder ME, Van Putten WL, Klijn JG. Cathepsin D in primary breast cancer: prognostic evaluation involving 2810 patients. Br J Cancer 1999; 79: 300-307.
26. Witzig TE, Ingle JN, Cha SS, Schaid DJ, Tabery RL, Wold LE et al. DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer. Cancer 1994; 74: 1752-1761.
27. Mink D, Von Tongelen B, Villena-Heisen C, Heiss C, Schmidt W. Breast cancer and prognostic factors. Tumor size, degree of differentiation, proliferation kinetics and expression of steroid hormone receptors. Eur J Gynaecol Oncol 1994; 15: 424-436.